PLX · Protalix BioTherapeutics, Inc. · Debt
Market Cap
$212.71M
Shares
80.57M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1006281
CUSIP
74365A309
13F (30d)
41 filings
41 filers
Visit website
Investor relations